Recombinant interferon-gamma (rIFN-gamma) in dermatology
This paper gives a short review on the function, pharmacokinetics, and therapeutic application of recombinant interferon-gamma (rIFN-gamma) in dermatology. Simultaneously, our own experiences are presented for 57 patients (phase II study) suffering from genital warts (21 patients), psoriatic arthritis (10 patients), psoriasis vulgaris (three patients), malignant melanoma (six patients), bowenoid papulosis (four patients), Behcet's disease (four patients), basal cell carcinoma (six patents), as well as herpes simplex recidivans, epidermodysplasia verruciformis, and mycosis fungoides (one patient each).
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Gustav Mahrle, Hans Joachim Schulze Source Type: research
More News: Arthritis | Basal Cell Carcinoma | Behcet's Disease | Cancer & Oncology | Carcinoma | Cold Sores | Cutaneous T cell lymphoma | Dermatology | Genital Herpes | Genital Warts | Herpes | Melanoma | Mycosis Fungoides | Psoriasis | Psoriatic Arthritis | Rheumatology | Skin | Skin Cancer | Study | Warts